Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Scholar Rock (SRRK)

Scholar Rock Holdings Corporation
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:SRRK
DateTimeSourceHeadlineSymbolCompany
10/01/202212:30Business WireScholar Rock Provides Corporate Update and Highlights Priorities for 2022NASDAQ:SRRKScholar Rock Holdings Corporation
04/01/202221:01Business WireScholar Rock to Present at the 40th Annual J.P. Morgan Healthcare ConferenceNASDAQ:SRRKScholar Rock Holdings Corporation
30/11/202121:11Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SRRKScholar Rock Holdings Corporation
30/11/202121:05Business WireScholar Rock Announces Design of Phase 3 SAPPHIRE Clinical Trial Evaluating Apitegromab in Non-Ambulatory Patients with Type 2 and Type 3 Spinal Muscular Atrophy (SMA)NASDAQ:SRRKScholar Rock Holdings Corporation
17/11/202121:46Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SRRKScholar Rock Holdings Corporation
12/11/202112:05Business WireScholar Rock Presents Data from Part A of the DRAGON Phase 1 Trial Evaluating SRK-181 as Monotherapy and in Combination with Anti-PD-(L)1 for the Treatment of Solid Tumors -- Announces Advancement into Part BNASDAQ:SRRKScholar Rock Holdings Corporation
09/11/202114:13Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SRRKScholar Rock Holdings Corporation
09/11/202113:31Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:SRRKScholar Rock Holdings Corporation
09/11/202113:05Business WireScholar Rock Reports Third Quarter 2021 Financial Results and Highlights Business ProgressNASDAQ:SRRKScholar Rock Holdings Corporation
02/11/202120:01Business WireScholar Rock to Present at Upcoming Healthcare ConferencesNASDAQ:SRRKScholar Rock Holdings Corporation
05/10/202113:16Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SRRKScholar Rock Holdings Corporation
03/10/202113:00Business WireScholar Rock to Present Apitegromab TOPAZ Phase 2 Pharmacologic Data at the 2021 World Congress of NeurologyNASDAQ:SRRKScholar Rock Holdings Corporation
30/09/202116:45Business WireScholar Rock Presents Exploratory Responder Analysis on Efficacy Data from the Apitegromab TOPAZ Phase 2 Trial at the Child Neurology Society Annual MeetingNASDAQ:SRRKScholar Rock Holdings Corporation
28/09/202121:01Business Wire Scholar Rock Announces Issuance of U.S. Patent Protecting SRK-181, an Inhibitor of TGFβ1 ActivationNASDAQ:SRRKScholar Rock Holdings Corporation
23/09/202116:31Business Wire Scholar Rock Presents Additional Data Analyses from the Apitegromab TOPAZ Phase 2 Trial at the World Muscle Society 2021 Virtual CongressNASDAQ:SRRKScholar Rock Holdings Corporation
22/09/202121:01Business WireScholar Rock to Present at the 2021 Cantor Virtual Global Healthcare ConferenceNASDAQ:SRRKScholar Rock Holdings Corporation
21/09/202121:47Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SRRKScholar Rock Holdings Corporation
16/08/202121:05Business WireScholar Rock Appoints Caryn Parlavecchio as Chief Human Resources OfficerNASDAQ:SRRKScholar Rock Holdings Corporation
10/08/202122:02Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:SRRKScholar Rock Holdings Corporation
10/08/202121:18Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SRRKScholar Rock Holdings Corporation
10/08/202121:15Business WireScholar Rock Reports Second Quarter 2021 Financial Results and Highlights Business ProgressNASDAQ:SRRKScholar Rock Holdings Corporation
10/08/202115:35Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:SRRKScholar Rock Holdings Corporation
05/08/202121:01Business WireScholar Rock to Present at the 2021 Wedbush PacGrow Healthcare ConferenceNASDAQ:SRRKScholar Rock Holdings Corporation
03/08/202112:30Business WireScholar Rock Announces Leadership ChangeNASDAQ:SRRKScholar Rock Holdings Corporation
28/07/202121:18Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SRRKScholar Rock Holdings Corporation
18/06/202113:00Business WireScholar Rock to Present Apitegromab TOPAZ Phase 2 Trial Results Highlighting Pharmacokinetic (PK) & Pharmacodynamic (PD) Data...NASDAQ:SRRKScholar Rock Holdings Corporation
15/06/202115:09Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SRRKScholar Rock Holdings Corporation
11/06/202112:30Business WireScholar Rock Presents TOPAZ Phase 2 Data Showing the Transformative Potential of Apitegromab in Patients with Type 2 & 3 Spin...NASDAQ:SRRKScholar Rock Holdings Corporation
07/06/202112:30Business WireScholar Rock to Present Apitegromab Clinical Data from the TOPAZ Phase 2 Trial in Patients with Type 2 & 3 Spinal Muscular At...NASDAQ:SRRKScholar Rock Holdings Corporation
02/06/202113:01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SRRKScholar Rock Holdings Corporation
 Showing the most relevant articles for your search:NASDAQ:SRRK

Your Recent History

Delayed Upgrade Clock